• Home
  • Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial - Authors' reply.

Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial - Authors' reply.

Author List
Rugo HS, Bardia A, Tolaney S
Publication
Lancet (London, England)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/532620653
Publication Year
2024
PubMed ID
39067902
Publication Title
Rugo HS, Bardia A, Tolaney S. Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial - Authors' reply. Lancet. 2024 Jul 27; 404(10450):339-340.